2-(1-ethyl-4-pyrazolyl)-4-quinolinecarboxylic acid

2-(1-ethyl-4-pyrazolyl)-4-quinolinecarboxylic acid, often shortened to **EPQCA**, is a synthetic compound with interesting pharmacological properties. It's not widely known or used in mainstream medicine, but it's been a subject of research for its potential in several areas.

**Key Properties and Potential Uses:**

* **Anti-inflammatory:** Studies have shown that EPQCA possesses anti-inflammatory properties, potentially acting by inhibiting the production of inflammatory mediators like TNF-α. This has implications for research into treating conditions like arthritis.
* **Anti-cancer:** Some research suggests that EPQCA might exhibit anti-cancer effects, potentially by targeting specific cancer cell pathways. However, the exact mechanism and efficacy need further investigation.
* **Antioxidant:** EPQCA has been shown to possess antioxidant activity, which means it can protect cells from damage caused by free radicals. This could be relevant for research into aging and neurodegenerative diseases.
* **Other potential applications:** EPQCA has been explored for its potential in treating other conditions like asthma, Alzheimer's disease, and even as a possible insecticide.

**Why is it important for research?**

* **Novelity:** EPQCA is a relatively new compound, and research on its pharmacological properties is still ongoing. This means there's potential for new discoveries and potential uses in medicine.
* **Multi-target properties:** The fact that EPQCA shows activity in different areas like inflammation, cancer, and antioxidant properties makes it an interesting subject for research. It could lead to the development of new drugs with multiple therapeutic benefits.
* **Drug development:** The potential of EPQCA as a drug candidate, especially for treating inflammatory conditions and certain cancers, has motivated research into its development, including exploring different derivatives and delivery methods.

**Important Note:**

While EPQCA shows promise, it's essential to emphasize that research is still ongoing, and more studies are needed to fully understand its efficacy, safety, and potential side effects. It's not yet approved for any clinical use, and it should not be considered a viable treatment option without further research and medical supervision.